Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug;29(5):415-25.
doi: 10.1177/1533317513518651. Epub 2014 Jan 8.

The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis

Gholamreza Azizi  1 , Nikoo Khannazer  2 , Abbas Mirshafiey  3
Affiliations
Review

The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis

Gholamreza Azizi et al. Am J Alzheimers Dis Other Demen. 2014 Aug.

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder and leading cause of dementia, which begins with impaired memory. The neuropathological hallmarks of AD include destructive alterations of neurons by neurofibrillary tangles, neuritic amyloid plaques, and neuroinflammatory process in the brain. Chemokines have a major role in inflammatory cell attraction and glial cell activation and/or modulation in the central nervous system. Moreover, the clinical and immunopathological evidence could show dual key role of chemokines in their pro- and anti-inflammatory properties in AD. However, their effects in neurodegeneration and/or neuroprotection remain an area of investigation. This review article provides an overview of characteristic, cellular source and activity of chemokines, and their roles in neuronal glial cell interaction in AD.

Keywords: Alzheimer’s disease; CCL2; CCL3; CCL5; CX3CL1; CXCL12; CXCL8; MIF; chemokine; inflammation; neurodegeneration.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Passos GF, Figueiredo CP, Prediger RD, et al. . Involvement of phosphoinositide 3-kinase gamma in the neuro-inflammatory response and cognitive impairments induced by beta-amyloid 1-40 peptide in mice. Brain Behav Immun. 2010;24(3):493–501. - PubMed
    1. Farfara D, Lifshitz V, Frenkel D. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer’s disease. J Cell Mol Med. 2008;12(3):762–780. - PMC - PubMed
    1. Higuchi M, Hatta K, Honma T, et al. . Association between altered systemic inflammatory interleukin-1beta and natural killer cell activity and subsequently agitation in patients with Alzheimer disease. Int J Geriatr Psychiatry. 2010;25(6):604–611. - PubMed
    1. González-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci. 1999;22:219–240. - PubMed
    1. Heneka MT, O'Banion MK, Terwel D, Kummer MP. Neuroinflammatory processes in Alzheimer’s disease. J Neural Transm. 2010;117(8):919–947. - PubMed